Natco Pharma to price Risdiplam at ₹15,900
Natco Pharma updates on Risdiplam launch in India, Delhi High Court denies Roche's injunction plea, pricing set at ₹15,900.
Natco Pharma aims to launch generic of Roche’s rare disease drug after favourable ruling in patent infringement case
The company said it has decided to price its version of Risdiplam product at Rs 15,900, and further added that it intends to ...
Natco Pharma shares legal update on Risdiplam product; stock up 3%
The stock rose 2.95 per cent to hit a high of Rs 789. It was last seen trading 1.44 per cent up at Rs 777.45. At this price, ...
Natco to price Risdiplam generic at ₹15,900
Natco Pharma plans to launch generic Risdiplam pending Delhi High Court decision, offering discounts to patients.
Natco Pharma update on launch of Risdiplam in India
The Company has received numerous enquiries from investors and patients about the launch, availability and pricing of generic version of Risdiplam in the Indian market. The Company wishes to clarify ...
The Print8h
Big buzz over Mounjaro launch but here’s why India’s anti-obesity drug market may only take off next yr
India’s obesity crisis fuels a $2.6 bn drug race as pharma firms rush to launch affordable semaglutide generics, aiming to ...
Share Market Highlights: Sensex jumps 1,089 points, Nifty closes above 22,500; rupee falls 51 paise
India’s benchmark indices bounced back strongly on Tuesday, recouping overnight losses to end over 1.5% higher. The Sensex ...
Indiatimes21h
Mankind Pharma Share Price
Mankind Pharma Ltd., incorporated in the year 1991, is a Small Cap company (having a market cap of Rs 1,01,128.40 Crore) operating in Pharmaceuticals sector. Mankind Pharma Ltd. key Products/Revenue ...